Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2026-03-28 @ 1:56 PM
Study NCT ID:
NCT02819804
Status:
TERMINATED
Last Update Posted:
2020-02-11
First Post:
2016-06-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nivolumab and Dasatinib in Treating Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Sponsor:
Northwestern University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | B Acute Lymphoblastic Leukemia With t(9;22)(q34;q11.2); BCR-ABL1 | View |
| None | Recurrent Adult Acute Lymphoblastic Leukemia | View |
| None | Recurrent Childhood Acute Lymphoblastic Leukemia | View |
| None | Refractory Adult Acute Lymphoblastic Leukemia | View |
| None | Refractory Childhood Acute Lymphoblastic Leukemia | View |
Keywords: